Atıf Formatları
Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. TASOVA Et Al. , "Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey," AASLD - TASL CONNECT REGIONAL MEETING , 2019

TASOVA, Y. Et Al. 2019. Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey. AASLD - TASL CONNECT REGIONAL MEETING .

TASOVA, Y., YAMAZHAN, T., ESEN, Ş., ÖZTOPRAK ÇUVALCI, N., ÖNLEN, Y., SARI, N. D., ... ESEN YILDIZ, İ.(2019). Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey . AASLD - TASL CONNECT REGIONAL MEETING

TASOVA, YESIM Et Al. "Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey," AASLD - TASL CONNECT REGIONAL MEETING, 2019

TASOVA, YESIM Et Al. "Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey." AASLD - TASL CONNECT REGIONAL MEETING , 2019

TASOVA, Y. Et Al. (2019) . "Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey." AASLD - TASL CONNECT REGIONAL MEETING .

@conferencepaper{conferencepaper, author={YESIM TASOVA Et Al. }, title={Efficiency and safety of direct-acting antiviral in cirrhotic hepatitisC infection patients: Real-life data from Turkey}, congress name={AASLD - TASL CONNECT REGIONAL MEETING}, city={}, country={}, year={2019}}